valine has been researched along with Purpura, Thrombotic Thrombocytopenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, WR; Chulay, JD; Feinberg, JE | 1 |
| Azoulay, E; Coudrec, LJ; Massiani, MA; Rivaud, E; Vincent, F | 1 |
1 trial(s) available for valine and Purpura, Thrombotic Thrombocytopenic
| Article | Year |
|---|---|
Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Double-Blind Method; Hemolytic-Uremic Syndrome; HIV Infections; Humans; Male; Middle Aged; Prodrugs; Prospective Studies; Purpura, Thrombotic Thrombocytopenic; Risk Factors; Valacyclovir; Valine | 1997 |
1 other study(ies) available for valine and Purpura, Thrombotic Thrombocytopenic
| Article | Year |
|---|---|
Valacyclovir hydrochloride therapy and thrombotic thrombocytopenic purpura in an HIV-infected patient.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; HIV-1; Humans; Keratitis, Herpetic; Male; Middle Aged; Prodrugs; Purpura, Thrombotic Thrombocytopenic; Recurrence; Valacyclovir; Valine | 2000 |